Fmoc-L-Ile-CHN2

Fmoc-L-Ile-CHN2 is an Fmoc-protected L-isoleucine derivative bearing a terminal diazomethyl functionality (CHN2) that functions as a reactive, stereochemically defined side-chain-modified amino acid building block. The molecule retains the chiral center of L-isoleucine and presents an N-Fmoc carbamate for base-stable handling during peptide assembly, while the diazo group introduces a controllable carbene precursor for downstream C-C and C-heteroatom bond formation. The isoleucine side chain provides hydrophobic steric features that can influence peptide conformation and reactivity during coupling and post-assembly transformations. The diazomethyl group can participate in synthetic derivatization under appropriate conditions, enabling conversion into functionalized motifs while preserving the peptide-compatible backbone protected by Fmoc.

1. Peptide Synthesis

Fmoc-L-Ile-CHN2 is suitable for solid-phase peptide synthesis workflows where the N-Fmoc group supports iterative deprotection and coupling cycles without exposing the amino acid nitrogen prematurely. The protected amino acid format, together with the L-configuration, enables incorporation as a defined residue within peptide sequences, while the diazomethyl side-chain functionality can be carried through assembly for later on-resin or post-cleavage transformations. The isoleucine side chain contributes hydrophobic packing that can affect peptide folding propensity and reactivity accessibility of the diazo handle. The resulting diazo-bearing peptides serve as precursors for generating peptide analogs and post-synthetic modifications that expand peptide library diversity.

2. Peptidomimetics Construction

Fmoc-L-Ile-CHN2 is applied in peptidomimetic and scaffold-building strategies that use diazo chemistry to introduce new carbon frameworks onto amino acid-derived backbones. The diazomethyl (CHN2) group can be converted into carbene-derived products, enabling installation of substituents that mimic or diversify side-chain topology relative to native isoleucine. The Fmoc-protected amino acid architecture supports controlled assembly of fragments, allowing stereodefined incorporation of the L-isoleucine core before diazo conversion. Downstream, diazo-derived transformations can generate constrained or functionalized peptide-like structures used in molecular design and synthetic methodology development.

3. Chemical Biology Labeling

Fmoc-L-Ile-CHN2 is relevant to chemical biology research that requires site-specific functionalization of peptides or biomolecule conjugates using diazo-based reactive intermediates. The compound's amino acid backbone protection strategy (Fmoc carbamate) allows preparation of diazo-functional peptide building blocks that can be coupled to targeting sequences or carrier proteins under peptide-compatible conditions. The diazomethyl functionality provides a handle for selective derivatization to introduce new linkages, enabling construction of labeled probes for studying biomolecular interactions. The L-isoleucine stereochemical fidelity helps maintain defined spatial presentation of the reactive handle in the resulting conjugates.

4. SAR Studies

Fmoc-L-Ile-CHN2 is utilized in structure-activity relationship studies where systematic side-chain diversification is needed on an amino acid-derived scaffold. The diazomethyl substituent enables rapid generation of analog series through carbene precursor transformations, while the isoleucine-derived hydrophobic context helps maintain comparable steric and electronic environments across analogs. The Fmoc-protected format supports consistent peptide coupling chemistry, helping researchers access multiple derivatives that differ primarily at the diazo-derived modification site. The resulting analogs can be used to map how side-chain geometry and newly installed functional groups influence molecular recognition in SAR workflows.

5. Process Chemistry Intermediate

Fmoc-L-Ile-CHN2 can serve as a process chemistry intermediate for manufacturing routes that require a chiral, Fmoc-protected amino acid precursor bearing a controlled diazo functionality. The combination of a base-labile Fmoc protecting group and a diazo handle allows staged processing, where peptide assembly compatibility is maintained until planned conversion to diazo-derived products. The L-isoleucine stereocenter and protected amino acid format support reproducible feedstock preparation for downstream derivatization steps in fine chemical synthesis. The compound can be employed to produce diazo-functional peptides and peptide fragments used as intermediates for specialty chemical production and applied peptide chemistry supply chains.

1. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

2. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore

3. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling

4. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

5. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII